nNGM Centers

Centralized Testing - Decentral Treatment

Already with the beginning of the nNGM initiative, the 15 nNGM centers together perform molecular multiplex analyses of about 10,000 patients / year corresponding to roughly one third of the annually newly diagnosed patients with advanced NSCLC in Germany.

The nNGM philosophy of centralized testing, consulting, evaluation and decentral treatment makes the establishment of regional networks around the nNGM centers crucial for success of this initiative. 



Steering Board

Stand: 10. April 2019